(Q38153187)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24131976%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

title

Male breast cancer: genetics, epigenetics, and ethical aspects (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24131976%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

0 references

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24131976%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Valentina Silvestri

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24131976%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Matteo Gulino

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24131976%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

P Rizzolo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24131976%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

R Pinto

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24131976%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

K Danza

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24131976%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

M Falchetti

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24131976%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

P Frati

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24131976%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

L Ottini

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24131976%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

publication date

1 November 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24131976%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24131976%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

volume

24 Suppl 8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24131976%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

viii75-viii82

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24131976%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

cites work

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

An international comparison of male and female breast cancer incidence rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

The genetic epidemiology of breast cancer genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Multidisciplinary meeting on male breast cancer: summary and research recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Cancer epigenomics: DNA methylomes and histone-modification maps

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Causes and consequences of microRNA dysregulation in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Novel genetic variants in microRNA genes and familial breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

MicroRNA function in cancer: oncogene or a tumor suppressor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Comparison of BRCA1 polymorphisms, rare sequence variants and/or missense mutations in unaffected and breast/ovarian cancer populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Association between the BRCA2 N372H variant and male breast cancer risk: a population-based case-control study in Tuscany, Central Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

A review of the diagnosis and management of male breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Large genomic rearrangements of the BRCA1 and BRCA2 genes: review of the literature and report of a novel BRCA1 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Phenotype-genotype correlation in familial breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Pathology and gene expression of hereditary breast tumors associated with BRCA1, BRCA2 and CHEK2 gene mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Pathology of hereditary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Role of CHEK2*1100delC in unselected series of non-BRCA1/2 male breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

CHEK2 1100delC is not a risk factor for male breast cancer population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

The CHEK2 c.1100delC mutation plays an irrelevant role in breast cancer predisposition in Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

A recurrent mutation in PALB2 in Finnish cancer families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Mutations in BRCA2 and PALB2 in male breast cancer cases from the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Mutation analysis of BRIP1 in male breast cancer cases: a population-based study in Central Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Mutation screening of RAD51C in male breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Rare mutations in XRCC2 increase the risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Genome-wide association study identifies novel breast cancer susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Genome-wide association study identifies five new breast cancer susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Genome-wide association analysis identifies three new breast cancer susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Architecture of inherited susceptibility to common cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Genetic susceptibility to breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

An 8q24 gene desert variant associated with prostate cancer risk confers differential in vivo activity to a MYC enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Multiple loci with different cancer specificities within the 8q24 gene desert

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Genetic heterogeneity of 8q24 region in susceptibility to cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Exploring the link between germline and somatic genetic alterations in breast carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Genetic susceptibility loci for breast cancer by estrogen receptor status

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Genetic variants at chromosomes 2q35, 5p12, 6q25.1, 10q26.13, and 16q12.1 influence the risk of breast cancer in men

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

The inheritance of epigenetic defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Breast cancer epigenetics: from DNA methylation to microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

The epigenetics of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Promoter hypermethylation in male breast cancer: analysis by multiplex ligation-dependent probe amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

RASSF1A inhibits estrogen receptor alpha expression and estrogen-independent signalling: implications for breast cancer development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Different methylation and microRNA expression pattern in male and female familial breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

miRNA_Targets: a database for miRNA target predictions in coding and non-coding regions of mRNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

MicroRNA mir-346 targets the 5'-untranslated region of receptor-interacting protein 140 (RIP140) mRNA and up-regulates its protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Interactions of intergenic microRNAs with mRNAs of genes involved in carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Principles of microRNA involvement in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Tumour invasion and metastasis initiated by microRNA-10b in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

MicroRNA expression profiling of male breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Identification of differentially expressed microRNAs in human male breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Intracellular and extracellular microRNAs in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Personalized medicine: new genomics, old lessons

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Male cancer: a qualitative study of male breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

The role of disease characteristics in the ethical debate on personal genome testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Hereditary breast cancer: from molecular pathology to tailored therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

The emerging landscape of breast cancer susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Clinical and pathologic characteristics of BRCA-positive and BRCA-negative male breast cancer patients: results from a collaborative multicenter study in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

BRCA1/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany: a population-based study in central Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Founder mutations account for the majority of BRCA1-attributable hereditary breast/ovarian cancer cases in a population from Tuscany, Central Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

BRCA1/BRCA2 rearrangements and CHEK2 common mutations are infrequent in Italian male breast cancer cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Fanconi anemia and breast cancer susceptibility meet again

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Are PALB2 mutations associated with increased risk of male breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

PALB2 mutations in male breast cancer: a population-based study in Central Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

A common coding variant in CASP8 is associated with breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

Common variants on chromosome 5p12 confer susceptibility to estrogen receptor–positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316

A Range of Cancers Is Associated with the rs6983267 Marker on Chromosome 8

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT316